Target
Interleukin-1 receptor-associated kinase 4
Ligand
BDBM50242694
Substrate
n/a
Meas. Tech.
ChEMBL_1672106 (CHEMBL4022135)
IC50
35±n/a nM
Citation
 Smith, GFAltman, MDAndresen, BBaker, JBrubaker, JDChen, HChen, YChilders, MDonofrio, AFerguson, HFischer, CFischmann, TOGibeau, CHicks, AJin, SKattar, SKleinschek, MALeccese, ELesburg, CLi, CLim, JLiu, DMaclean, JKFMansoor, FMoy, LYMulrooney, EFNecheva, ASPresland, JRakhilina, LYang, RTorres, LZhang-Hoover, JNorthrup, A Identification of quinazoline based inhibitors of IRAK4 for the treatment of inflammation. Bioorg Med Chem Lett 27:2721-2726 (2017) [PubMed]  Article 
Target
Name:
Interleukin-1 receptor-associated kinase 4
Synonyms:
IRAK-4 | IRAK4 | IRAK4_HUMAN | Interleukin-1 receptor-associated kinase 4 (IRAK-4) | Interleukin-1 receptor-associated kinase 4 (IRAK4) | Renal carcinoma antigen NY-REN-64
Type:
Protein
Mol. Mass.:
51519.08
Organism:
Homo sapiens (Human)
Description:
Q9NWZ3
Residue:
460
Sequence:
MNKPITPSTYVRCLNVGLIRKLSDFIDPQEGWKKLAVAIKKPSGDDRYNQFHIRRFEALLQTGKSPTSELLFDWGTTNCTVGDLVDLLIQNEFFAPASLLLPDAVPKTANTLPSKEAITVQQKQMPFCDKDRTLMTPVQNLEQSYMPPDSSSPENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS
  
Inhibitor
Name:
BDBM50242694
Synonyms:
CHEMBL4060699 | US9932350, 3-1
Type:
Small organic molecule
Emp. Form.:
C18H21N5
Mol. Mass.:
307.3928
SMILES:
N#Cc1ccc2ncnc(N[C@H]3CC[C@@H](CC3)N3CCC3)c2c1 |r,wU:11.10,wD:14.17,(1.49,-18.86,;2.83,-19.63,;4.17,-20.4,;4.16,-21.94,;5.5,-22.72,;6.83,-21.94,;8.17,-22.7,;9.5,-21.93,;9.49,-20.38,;8.16,-19.62,;8.15,-18.08,;9.48,-17.3,;9.46,-15.77,;10.8,-15,;12.14,-15.76,;12.14,-17.31,;10.81,-18.08,;13.47,-14.99,;14.95,-15.39,;15.35,-13.9,;13.86,-13.5,;6.83,-20.39,;5.49,-19.63,)|
Structure:
Search PDB for entries with ligand similarity: